AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
AMZN   2,421.86 (-0.62%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
BAC   24.28 (+7.15%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
AMZN   2,421.86 (-0.62%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
BAC   24.28 (+7.15%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
AMZN   2,421.86 (-0.62%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
BAC   24.28 (+7.15%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
AMZN   2,421.86 (-0.62%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
BAC   24.28 (+7.15%)
Log in

OTCMKTS:PBSVPharma Bio Serv Stock Price, Forecast & News

$0.85
0.00 (0.00 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.85
Now: $0.85
$0.85
50-Day Range
$0.82
MA: $0.85
$0.96
52-Week Range
$0.60
Now: $0.85
$1.15
VolumeN/A
Average Volume6,265 shs
Market Capitalization$19.90 million
P/E Ratio9.45
Dividend Yield8.82%
Beta0.25
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.79 out of 5 stars


Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryN/A
SectorBusiness Services
Current SymbolOTCMKTS:PBSV
CUSIPN/A
Phone787-278-2709

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.51 million
Cash Flow$0.09 per share
Book Value$0.88 per share

Profitability

Net Income$2.09 million

Miscellaneous

Employees185
Market Cap$19.90 million
Next Earnings Date6/12/2020 (Estimated)
OptionableNot Optionable

Receive PBSV News and Ratings via Email

Sign-up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter.

Pharma Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions

How has Pharma Bio Serv's stock been impacted by COVID-19 (Coronavirus)?

Pharma Bio Serv's stock was trading at $0.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PBSV shares have increased by 0.0% and is now trading at $0.85. View which stocks have been most impacted by Coronavirus.

When is Pharma Bio Serv's next earnings date?

Pharma Bio Serv is scheduled to release its next quarterly earnings announcement on Friday, June 12th 2020. View our earnings forecast for Pharma Bio Serv.

How were Pharma Bio Serv's earnings last quarter?

Pharma Bio Serv Inc (OTCMKTS:PBSV) issued its quarterly earnings data on Monday, March, 16th. The company reported $0.02 earnings per share (EPS) for the quarter. The company had revenue of $4.61 million for the quarter. Pharma Bio Serv had a return on equity of 10.10% and a net margin of 10.97%. View Pharma Bio Serv's earnings history.

Has Pharma Bio Serv been receiving favorable news coverage?

Media coverage about PBSV stock has trended extremely negative on Tuesday, according to InfoTrie. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Pharma Bio Serv earned a coverage optimism score of -5.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutPharma Bio Serv.

Who are some of Pharma Bio Serv's key competitors?

What other stocks do shareholders of Pharma Bio Serv own?

Who are Pharma Bio Serv's key executives?

Pharma Bio Serv's management team includes the following people:
  • Ms. Elizabeth Plaza, Founder, Chairman & Sr. Strategic Consultant (Age 55)
  • Mr. Victor Sanchez, CEO, Pres & Pres of European Operations (Age 48)
  • Mr. Pedro J. Lasanta, CFO, VP of Fin. & Admin. and Sec. (Age 59)

What is Pharma Bio Serv's stock symbol?

Pharma Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."

How do I buy shares of Pharma Bio Serv?

Shares of PBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pharma Bio Serv's stock price today?

One share of PBSV stock can currently be purchased for approximately $0.85.

How big of a company is Pharma Bio Serv?

Pharma Bio Serv has a market capitalization of $19.90 million and generates $19.51 million in revenue each year. The company earns $2.09 million in net income (profit) each year or $0.09 on an earnings per share basis. Pharma Bio Serv employs 185 workers across the globe.

What is Pharma Bio Serv's official website?

The official website for Pharma Bio Serv is www.pharmabioserv.com.

How can I contact Pharma Bio Serv?

Pharma Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The company can be reached via phone at 787-278-2709 or via email at [email protected]

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.